Essilor International
38
9
16
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
5.3%
2 terminated/withdrawn out of 38 trials
84.6%
-1.9% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (38)
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (DAL)
Role: lead
Comparing Myopia Control Spectacle Lenses for Visual Comfort, Adaptation, and Satisfaction in Myopic Children
Role: lead
Visual Performance of Highly Aspherical Lenslet Spectacles in Children (Ancillary to WS10246)
Role: lead
Comparison of Efficacy Between Two Myopia Control Lenses
Role: lead
Study Comparing Eye Growth Over Time in Children Using Two Myopia Control Lenses
Role: lead
Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol
Role: lead
Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years
Role: lead
Targeted Lens Intervention for Myopic Anisometropia in Children
Role: lead
A Study on Body Posture and Eye Movements During Screen Usage on Adults Aged 18 to 65 Wearing Various Types of Eyeglasses
Role: lead
Study of Blinking as a Function of Tear Film Quality
Role: lead
Eye Imaging for the Study of Childhood Myopia
Role: lead
Visual and Postural Behavior in Myopic and Non-Myopic Teenagers
Role: lead
Stellest Lens Wear in Adult Progressing Myopes
Role: collaborator
Understanding How Young Adults Perceive Blurred Image Quality and Creating a Model Predicting Their Quality Ratings
Role: lead
An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children
Role: lead
Development of a New Device and Method to Assess the Degree of Myopia and/or Astigmatism in Myopic People
Role: lead
Myopia Control With a Innovative Spectacle Lens
Role: lead
A Randomized Clinical Trial on the Effectiveness of Novel Plano Spectacle Lenses on Myopia Prevention in Pre-myopic Children
Role: collaborator
Essilor® Stellest® Lenses Multicentre European Study (SLOMES)
Role: lead
Efficacy and Safety of Spectacle Lenses With H.A.L.T. MAX Technology on High Myopia Control in Children and Adolescents
Role: collaborator